GLP-1 drugs promise wider health benefits, but experts urge caution on use
Summary
GLP-1 receptor agonists are reshaping care for type 2 diabetes, obesity, chronic kidney disease, and obstructive sleep apnea, with evidence for glycemic, weight...
Description
GLP-1 receptor agonists are reshaping care for type 2 diabetes, obesity, chronic kidney disease, and obstructive sleep apnea, with evidence for glycemic, weight...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source